Last updated 21 days ago

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

230 patients around the world
Available in Colombia, Brazil, United States, Argentina
Hoffmann-La Roche
5Research sites
230Patients around the world
This study is for people with
Breast Cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Centro Polivalente de Asistencia e Investigación Clínica - CER San Juan
Centro Polivalente de Asistencia e Investigación Clínica - CER San Juan
Recruiting
Laprida 532 Este, San Juan
Hospital Provincial del Centenario - Rosario, Santa Fe
Recruiting
Urquiza 3101, Rosario, Santa Fe
Fundación CENIT para la Investigación en Neurociencias
Recruiting
Juncal 2222, C1125 CABA, Argentina
Instituto de Oncología de Rosario - IOR
Recruiting
Córdoba 2457, Rosario, Santa Fe
Centro Oncológico Korben
Recruiting
Cdad. de La Paz 353, C1426 CABA, Argentina
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy